Definitive Healthcare (DH) Stock Forecast, Price Target & Predictions
DH Stock Forecast
Definitive Healthcare stock forecast is as follows: an average price target of $6.08 (represents a 47.57% upside from DH’s last price of $4.12) and a rating consensus of 'Hold', based on 12 wall street analysts offering a 1-year stock forecast.
DH Price Target
The average price target for Definitive Healthcare (DH) is $6.08 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $4.00. This represents a potential 47.57% upside from DH's last price of $4.12.
DH Analyst Ratings
According to 12 Wall Street analysts, Definitive Healthcare's rating consensus is 'Hold'. The analyst rating breakdown for DH stock is 0 'Strong Buy' (0.00%), 4 'Buy' (33.33%), 7 'Hold' (58.33%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).
Definitive Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 17, 2024 | David Larsen | BTIG | $7.00 | $4.44 | 57.66% | 69.90% |
| Aug 09, 2024 | George Hill | Deutsche Bank | $5.00 | $3.87 | 29.20% | 21.36% |
| Aug 07, 2024 | Saket Kalia | Barclays | $4.00 | $3.65 | 9.59% | -2.91% |
| Aug 06, 2024 | Craig Hettenbach | Morgan Stanley | $5.00 | $3.72 | 34.41% | 21.36% |
| Aug 05, 2024 | Kash Rangan | Goldman Sachs | $8.00 | $3.55 | 125.35% | 94.17% |
| Jul 31, 2024 | David Grossman | Stifel Nicolaus | $7.50 | $3.41 | 119.94% | 82.04% |
| May 09, 2024 | Saket Kalia | Barclays | $7.00 | $5.35 | 30.84% | 69.90% |
| May 08, 2024 | George Hill | Deutsche Bank | $7.00 | $5.35 | 30.84% | 69.90% |
| Jan 06, 2023 | Morgan Stanley | $18.00 | $10.57 | 70.29% | 336.89% | |
| Aug 08, 2022 | Morgan Stanley | $34.00 | $25.78 | 31.89% | 725.24% | |
| Aug 08, 2022 | Barclays | $23.00 | $25.10 | -8.37% | 458.25% | |
| Jul 06, 2022 | Ryan MacDonald | Needham | $30.00 | $24.66 | 21.65% | 628.16% |
| May 06, 2022 | Morgan Stanley | $37.00 | $19.95 | 85.46% | 798.06% |
The latest Definitive Healthcare stock forecast, released on Sep 17, 2024 by David Larsen from BTIG, set a price target of $7.00, which represents a 57.66% increase from the stock price at the time of the forecast ($4.44), and a 69.90% increase from DH last price ($4.12).
Definitive Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 8 |
| Avg Price Target | - | - | $6.31 |
| Last Closing Price | $4.12 | $4.12 | $4.12 |
| Upside/Downside | -100.00% | -100.00% | 53.16% |
In the current month, the average price target of Definitive Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Definitive Healthcare's last price of $4.12. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 08, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Sep 17, 2024 | BTIG | Buy | Initialise | |
| Aug 09, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Aug 07, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Aug 06, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Aug 05, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| May 09, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| May 08, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Feb 29, 2024 | Canaccord Genuity | Positive | Positive | Hold |
| Jan 17, 2024 | William Blair | Outperform | Outperform | Hold |
| Aug 15, 2023 | Jefferies | Buy | Buy | Hold |
| Aug 15, 2023 | Citigroup | Neutral | Neutral | Hold |
| Aug 15, 2023 | UBS | Outperform | Outperform | Hold |
| Aug 15, 2023 | Barclays | Overweight | Overweight | Hold |
| Jan 06, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
| Aug 08, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
| Aug 08, 2022 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Apr 25, 2022 | Zacks Investment Research | Sell | Downgrade | |
| Feb 24, 2022 | Credit Suisse | Neutral | Neutral | Hold |
Definitive Healthcare's last stock rating was published by Canaccord Genuity on Nov 08, 2024. The company gave DH a "Hold" rating, the same as its previous rate.
Definitive Healthcare Financial Forecast
Definitive Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $65.33M | $60.96M | $59.20M | $60.60M | $57.38M | $54.55M | $50.12M | $46.31M | $43.08M |
| Avg Forecast | $64.65M | $63.64M | $63.03M | $62.83M | $61.45M | $60.45M | $59.84M | $59.91M | $60.56M | $61.68M | $63.10M | $63.99M | $66.00M | $63.70M | $61.04M | $57.58M | $58.45M | $56.67M | $53.76M | $48.52M | $44.70M | $41.15M |
| High Forecast | $66.49M | $65.46M | $64.83M | $64.62M | $63.20M | $62.18M | $61.55M | $61.40M | $60.66M | $61.74M | $63.15M | $63.99M | $66.16M | $63.70M | $62.78M | $59.23M | $59.70M | $56.67M | $53.76M | $48.52M | $44.70M | $41.15M |
| Low Forecast | $63.39M | $62.41M | $61.81M | $61.61M | $60.26M | $59.28M | $58.68M | $58.84M | $60.39M | $61.62M | $63.06M | $63.99M | $65.75M | $63.70M | $59.85M | $56.47M | $57.61M | $56.67M | $53.76M | $48.52M | $44.70M | $41.15M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.00% | 1.03% | 1.04% | 1.01% | 1.01% | 1.03% | 1.04% | 1.05% |
Definitive Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $66.00M, with a low forecast of $65.75M, and a high forecast of $66.16M. DH's average Quarter revenue forecast represents a 1.04% increase compared to the company's last Quarter revenue of $65.33M (Sep 23).
Definitive Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-148.09M | $7.05M | $4.00K | $5.39M | $12.23M | $10.67M | $5.48M | $8.13M | $6.51M |
| Avg Forecast | $-2.00M | $-1.97M | $-1.95M | $-1.94M | $-1.90M | $-1.87M | $-1.85M | $-1.85M | $-1.87M | $-1.91M | $-1.95M | $7.80M | $-2.04M | $-1.97M | $-1.89M | $7.09M | $10.28M | $14.31M | $13.58M | $6.45M | $11.29M | $19.34M |
| High Forecast | $-1.96M | $-1.93M | $-1.91M | $-1.90M | $-1.86M | $-1.83M | $-1.81M | $-1.82M | $-1.87M | $-1.90M | $-1.95M | $9.36M | $-2.03M | $-1.97M | $-1.85M | $8.51M | $12.34M | $14.31M | $13.58M | $7.74M | $11.29M | $23.20M |
| Low Forecast | $-2.05M | $-2.02M | $-2.00M | $-2.00M | $-1.95M | $-1.92M | $-1.90M | $-1.90M | $-1.87M | $-1.91M | $-1.95M | $6.24M | $-2.04M | $-1.97M | $-1.94M | $5.68M | $8.23M | $14.31M | $13.58M | $5.16M | $11.29M | $15.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 75.25% | -3.74% | 0.00% | 0.52% | 0.85% | 0.79% | 0.85% | 0.72% | 0.34% |
4 analysts predict DH's average Quarter EBITDA for Sep 23 to be $-1.97M, with a high of $-1.97M and a low of $-1.97M. This is -127.90% lower than Definitive Healthcare's previous annual EBITDA (Jun 23) of $7.05M.
Definitive Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-171.53M | $-8.57M | $-15.60M | $6.74M | $-6.35M | $-9.58M | $-13.06M | $-14.76M | $-15.79M |
| Avg Forecast | $9.31M | $9.31M | $9.31M | $9.31M | $9.32M | $8.85M | $8.56M | $8.49M | $8.35M | $9.32M | $9.96M | $-7.83M | $9.02M | $7.07M | $7.14M | $-7.11M | $-12.27M | $5.54M | $6.18M | $-6.47M | $4.14M | $-10.77M |
| High Forecast | $9.66M | $9.66M | $9.66M | $9.66M | $9.67M | $9.18M | $8.87M | $8.81M | $8.66M | $9.67M | $10.04M | $-6.26M | $10.31M | $7.33M | $7.40M | $-5.69M | $-9.82M | $5.54M | $6.18M | $-5.17M | $4.14M | $-8.62M |
| Low Forecast | $9.08M | $9.08M | $9.08M | $9.08M | $9.09M | $8.63M | $8.34M | $7.55M | $8.14M | $9.09M | $9.88M | $-9.39M | $7.73M | $6.89M | $6.96M | $-8.54M | $-14.72M | $5.54M | $6.18M | $-7.76M | $4.14M | $-12.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -24.27% | -1.20% | 2.19% | -0.55% | -1.15% | -1.55% | 2.02% | -3.56% | 1.47% |
Definitive Healthcare's average Quarter net income forecast for Mar 23 is $-7.11M, with a range of $-8.54M to $-5.69M. DH's average Quarter net income forecast represents a -205.64% decrease compared to the company's last Quarter net income of $6.74M (Dec 22).
Definitive Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $37.35M | $38.37M | $37.06M | $38.74M | $34.90M | $32.98M | $31.75M | $29.02M | $22.26M |
| Avg Forecast | $33.48M | $32.96M | $32.64M | $32.53M | $31.82M | $31.30M | $30.99M | $31.02M | $31.36M | $31.94M | $32.68M | $28.81M | $34.18M | $32.99M | $31.61M | $26.19M | $36.71M | $29.34M | $27.84M | $23.81M | $23.14M | $30.05M |
| High Forecast | $34.43M | $33.90M | $33.57M | $33.46M | $32.73M | $32.20M | $31.87M | $31.80M | $31.41M | $31.97M | $32.70M | $34.57M | $34.26M | $32.99M | $32.51M | $31.43M | $44.05M | $29.34M | $27.84M | $28.57M | $23.14M | $36.05M |
| Low Forecast | $32.83M | $32.32M | $32.00M | $31.90M | $31.20M | $30.70M | $30.39M | $30.47M | $31.27M | $31.91M | $32.65M | $23.05M | $34.05M | $32.99M | $30.99M | $20.95M | $29.37M | $29.34M | $27.84M | $19.05M | $23.14M | $24.04M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 1.21% | 1.42% | 1.06% | 1.19% | 1.18% | 1.33% | 1.25% | 0.74% |
Definitive Healthcare's average Quarter SG&A projection for Dec 23 is $34.18M, based on 9 Wall Street analysts, with a range of $34.05M to $34.26M. The forecast indicates a -8.49% fall compared to DH last annual SG&A of $37.35M (Sep 23).
Definitive Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 9 | 4 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.50 | $-0.08 | $-0.14 | $0.06 | $-0.06 | $-0.10 | $-0.13 | $-0.16 | $-0.18 |
| Avg Forecast | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.07 | $0.07 | $0.07 | $0.08 | $0.09 | $0.08 | $0.08 | $0.06 | $0.06 | $0.04 | $0.04 | $0.05 | $0.05 | $0.04 | $0.04 | $0.01 |
| High Forecast | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.07 | $0.08 | $0.09 | $0.08 | $0.09 | $0.06 | $0.06 | $0.05 | $0.04 | $0.05 | $0.05 | $0.04 | $0.04 | $0.01 |
| Low Forecast | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.07 | $0.07 | $0.06 | $0.07 | $0.08 | $0.08 | $0.08 | $0.07 | $0.06 | $0.06 | $0.04 | $0.04 | $0.05 | $0.05 | $0.04 | $0.04 | $0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -24.70% | -1.25% | -3.13% | 1.53% | -1.31% | -1.84% | -3.67% | -4.55% | -25.93% |
According to 4 Wall Street analysts, Definitive Healthcare's projected average Quarter EPS for Mar 23 is $0.04, with a low estimate of $0.04 and a high estimate of $0.05. This represents a -30.23% decrease compared to DH previous annual EPS of $0.06 (Dec 22).
Definitive Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EVH | Evolent Health | $11.25 | $33.00 | 193.33% | Buy |
| FORA | Forian | $2.06 | $4.50 | 118.45% | Buy |
| SLP | Simulations Plus | $27.89 | $47.00 | 68.52% | Buy |
| DH | Definitive Healthcare | $4.11 | $6.08 | 47.93% | Hold |
| HCAT | Health Catalyst | $7.07 | $9.67 | 36.78% | Buy |
| CERT | Certara | $10.65 | $14.50 | 36.15% | Buy |
| PHR | Phreesia | $25.16 | $30.75 | 22.22% | Buy |
| PRVA | Privia Health Group | $19.55 | $23.00 | 17.65% | Buy |
| HQY | HealthEquity | $95.95 | $107.50 | 12.04% | Buy |
| HSTM | HealthStream | $31.80 | $29.00 | -8.81% | Buy |